HOME Top Market Reports Patient Registry Software Market by Database Type (Drug, Device, Diabetes, Cancer, Asthma, CKD), Software (Integrated, Standalone), Delivery (On-Premise, Cloud), Functionality (PHM, HIE, POC) & End User (Government, Hospital, Pharma) - Forecasts to 2021

Patient Registry Software Market by Database Type (Drug, Device, Diabetes, Cancer, Asthma, CKD), Software (Integrated, Standalone), Delivery (On-Premise, Cloud), Functionality (PHM, HIE, POC) & End User (Government, Hospital, Pharma) - Forecasts to 2021

By: marketsandmarkets.com
Publishing Date: July 2016
Report Code: HIT 3094

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The patient registry software market is expected to reach USD 1,314.3 Million by 2021 from USD 734.7 Million in 2016 at a CAGR of 12.3% from 2016 to 2021. Major factors driving the growth of this market include increasing government initiatives to build patient registries, growing pressure to improve the quality of care and minimize healthcare costs, increasing adoption of EHRs, the rising use of patient registry data for post-marketing surveillance, and increasing prevalence of chronic diseases. Moreover, the high adoption of information technology across the globe supports the growth of this market. On the other hand, data privacy and security concerns and lack of resources with cross-functional skills are hindering the growth of the patient registry software market.

The patient registry software market is categorized on the basis of product type, pricing model, deployment model, type of database, functionality, end user, and region. Based on product type, the market is categorized into standalone and integrated software. The integrated software segment is poised to grow at the highest CAGR during the forecast period due to the growing need for, and focus on, ensuring an integrated healthcare system.

North America is expected to dominate the global market in 2016, with the U.S. accounting for a major share of this regional market. However, Asia-Pacific is expected to grow at the highest CAGR during the forecast period, owing to the large population base, rising prevalence of chronic diseases, improvement of healthcare systems, and increasing government initiatives for the modernization of healthcare infrastructure.

The patient registry software market is fragmented with several global as well as local players. Players offer several products across different subsegments of this market. Key players in this market include Global Vision Technologies, Inc. (U.S.), Dacima Software, Inc. (Canada), FIGmd, Inc. (U.S.), CECity.com, Inc. (U.S.), Liaison Technologies, Inc. (U.S.), Advertek Incorporated (U.S.), ImageTrend, Inc. (U.S.), Phytel, Inc. (U.S.), Velos, Inc. (U.S.), INC Research Holdings, Inc. (U.S.), Quintiles Transnational Holdings Inc. (U.S.), IFA Systems AG (Germany), McKesson Corporation (U.S.), Optum, Inc. (U.S.), M2S, Inc. (U.S.), and Telligen, Inc. (U.S.).

Target Audience:

  • Patient registry software vendors/service providers
  • Healthcare IT service providers
  • Research and consulting firms
  • Healthcare insurance companies/payers
  • Healthcare institutions/providers (hospitals, medical groups, physician practices, community clinics, and outpatient clinics)
  • Venture capitalists
  • Government agencies
  • Health information exchanges
  • Accountable care organizations (ACOs)
  • Pharmaceutical, biotechnology, and medical device companies

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This report categorizes the patient registry software market into the following segments and subsegments.

Patient Registry Software Market, by Type of Database

  • Product Registries
    • Medical Device Registries
    • Drug Registries
  • Health Service Registries
  • Disease Registries
    • Diabetes Registries
    • Cardiovascular Registries
    • Cancer Registries
    • Rare Disease Registries
    • Asthma Registries
    • Chronic Kidney Disease Registries
    • Other Registries (ophthalmology, joint replacement, hemophilia registries, and neuromuscular disease)

Patient Registry Software Market, by Product Type

  • Integrated Software
  • Standalone Software

Patient Registry Software Market, by Pricing Model

  • Subscription Models
  • Ownership Models

Patient Registry Software Market, by Deployment Model

  • On-premise Models
  • Cloud-based Models

Patient Registry Software Market, by Functionality

  • Population Health Management (PHM)
  • Patient Care Management
  • Health Information Exchange (HIE)
  • Point of Care
  • Product Outcome Evaluation
  • Medical Research and Clinical Studies

Patient Registry Software Market, by End User

  • Government Organizations and Third-party Administrators (TPAs)
  • Hospitals
  • Private Payers
  • Pharmaceutical, Biotechnology, and Medical Device Companies
  • Research Centers

Patient Registry Software Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Rest of Europe (RoE)
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Rest of the World (RoW)

(Latin America, the Middle East, and Africa)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to 5).

Further Split of the RoW Patient Registry Software Market

Patient registry software market size and growth rate estimates of Latin America, the Middle East, and Africa

Table of Contents

1 Introduction (Page No. - 25)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 29)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
    2.3 Key Industry Insights
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 39)

4 Premium Insights (Page No. - 45)
    4.1 Patient Registry Software Market, By Type of Database
    4.2 Patient Registry Software Market, By Product Type
    4.3 Patient Registry Software Market, By Deployment Model
    4.4 Patient Registry Software Market, By Pricing Model
    4.5 Patient Registry Software Market, By Functionality
    4.6 Patient Registry Software Market, By End User
    4.7 Geographic Snapshot of the Patient Registry Software Market

5 Market Overview (Page No. - 49)
    5.1 Introduction
    5.2 Market Segmentation
    5.3 Market Dynamics
           5.3.1 Market Drivers
                    5.3.1.1 Government Initiatives to Build Patient Registries
                    5.3.1.2 Increasing Pressure to Improve the Quality of Care and Minimize Healthcare Costs
                    5.3.1.3 Increasing Adoption of Ehrs
                    5.3.1.4 Rising Use of Patient Registry Data for Post-Marketing Surveillance
                    5.3.1.5 Increasing Prevalence of Chronic Diseases
           5.3.2 Market Restraints
                    5.3.2.1 Data Privacy and Security Concerns
                    5.3.2.2 Dearth of Trained and Skilled Resources
           5.3.3 Market Opportunities
                    5.3.3.1 Rising Number of Accountable Care Organizations
                    5.3.3.2 Emergence of Cloud-Based Patient Registry Solutions
                    5.3.3.3 Subscription Models Present High Growth Potential
                    5.3.3.4 Shifting Focus Towards Patient-Powered Research Networks (PPRNS)
           5.3.4 Market Challenges
                    5.3.4.1 Lack of Interoperability
                    5.3.4.2 Reluctance Towards Adopting Advanced Systems

6 Patient Registry Software Market, By Type of Database (Page No. - 60)
    6.1 Introduction
    6.2 Product Registries
           6.2.1 Medical Device Registries
           6.2.2 Drug Registries
    6.3 Health Service Registries
    6.4 Disease Registries
           6.4.1 Diabetes Registries
           6.4.2 Cardiovascular Registries
           6.4.3 Cancer Registries
           6.4.4 Rare Disease Registries
           6.4.5 Asthma Registries
           6.4.6 Chronic Kidney Disease Registries
           6.4.7 Other Registries
7 Patient Registry Software Market, By Product Type (Page No. - 89)
    7.1 Introduction
    7.2 Standalone Software
    7.3 Integrated Software

8 Patient Registry Software Market, By Pricing Model (Page No. - 96)
    8.1 Introduction
    8.2 Subscription Models
    8.3 Ownership Models

9 Patient Registry Software Market, By Deployment Model (Page No. - 103)
    9.1 Introduction
    9.2 On-Premise Models
    9.3 Cloud-Based Models

10 Patient Registry Software Market, By Functionality (Page No. - 110)
     10.1 Introduction
     10.2 Population Health Management (PHM)
     10.3 Patient Care Management
     10.4 Health Information Exchange (HIE)
     10.5 Point of Care
     10.6 Product Outcome Evaluation
     10.7 Medical Research & Clinical Studies

11 Patient Registry Software Market, By End User (Page No. - 126)
     11.1 Introduction
     11.2 Government Organizations & Third-Party Administrators
     11.3 Hospitals and Medical Practices
     11.4 Private Payers
     11.5 Pharmaceutical, Biotechnology, and Medical Device Companies
     11.6 Research Centers

12 Patient Registry Software Market, By Region (Page No. - 141)
     12.1 Introduction
     12.2 North America
             12.2.1 U.S.
             12.2.2 Canada
     12.3 Europe
             12.3.1 Germany
             12.3.2 France
             12.3.3 U.K.
             12.3.4 Rest of Europe (RoE)
     12.4 Asia-Pacific
             12.4.1 Japan
             12.4.2 China
             12.4.3 India
             12.4.4 Rest of Asia-Pacific (RoAPAC)
     12.5 Rest of the World (RoW)

13 Competitive Landscape (Page No. - 205)
     13.1 Overview
     13.2 Competitive Situation and Trends
             13.2.1 Partnerships, Agreements, Collaborations, and Contracts
             13.2.2 New Product Launches & Product Upgrades
             13.2.3 Acquisitions
             13.2.4 Expansions
             13.2.5 Others

14 Company Profiles (Page No. - 211)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     14.1 Introduction
     14.2 Phytel, Inc. (An IBM Corporation Company)
     14.3 Imagetrend, Inc.
     14.4 Figmd, Inc.
     14.5 Liaison Technologies
     14.6 Quintiles Transnational Holdings, Inc.
     14.7 Advertek Incorporated
     14.8 Cecity, Inc. (A Premier, Inc. Company)
     14.9 Dacima Software, Inc.
     14.10 Global Vision Technologies, Inc. (GVT)
     14.11 IFA Systems AG
     14.12 Inc Research Holdings, Inc.
     14.13 M2S, Inc.
     14.14 Mckesson Corporation
     14.15 Optum, Inc. (A Part of Unitedhealth Group, Inc.)
     14.16 Telligen, Inc.
     14.17 Velos, Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

15 Appendix (Page No. - 239)
     15.1 Insights From Industry Experts
     15.2 Discussion Guide/Questionnaire
     15.3 Additional Developments, 2013–2016
     15.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     15.5 Introducing RT: Real-Time Market Intelligence
             15.5.1 Features and Benefits of Rt:
     15.6 Available Customizations
     15.7 Related Reports


List of Tables (250 Tables)

Table 1 Government Initiatives to Build Patient Registries: A Major Market Driver
Table 2 Data Privacy and Security Concerns: A Major Restraint for Market Growth
Table 3 Subscription Models to Offer High Growth Opportunities
Table 4 Interoperability—A Major Challenge to Market Growth
Table 5 Global Patient Registry Software Market Size, By Type of Database, 2014-2021 (USD Million)
Table 6 Global Patient Registry Software Market Size for Product Registries, By Type, 2014-2021 (USD Million)
Table 7 Global Patient Registry Software Market Size for Product Registries, By Region, 2014-2021 (USD Million)
Table 8 North America: Patient Registry Software Market Size for Product Registries, By Country, 2014-2021 (USD Million)
Table 9 Europe: Patient Registry Software Market Size for Product Registries, By Country, 2014-2021 (USD Million)
Table 10 Asia-Pacific: Patient Registry Software Market Size for Product Registries, By Country, 2014-2021 (USD Million)
Table 11 Medical Device Registries Market Size, By Region, 2014-2021 (USD Million)
Table 12 North America: Medical Device Registries Market Size, By Country, 2014-2021 (USD Million)
Table 13 Europe: Medical Device Registries Market Size, By Country, 2014-2021 (USD Million)
Table 14 Asia-Pacific: Medical Device Registries Market Size, By Country, 2014-2021 (USD Million)
Table 15 Global Drug Registries Market Size, By Region, 2014-2021 (USD Million)
Table 16 North America: Drug Registries Market Size, By Country, 2014-2021 (USD Million)
Table 17 Europe: Drug Registries Market Size, By Country, 2014-2021 (USD Million)
Table 18 Asia-Pacific: Drug Registries Market Size, By Country, 2014-2021 (USD Million)
Table 19 Global Patient Registry Software Market Size for Health Service Registries, By Region, 2014-2021 (USD Million)
Table 20 North America: Patient Registry Software Market Size for Health Service Registries, By Country, 2014-2021 (USD Million)
Table 21 Europe: Patient Registry Software Market Size for Health Service Registries, By Country, 2014-2021 (USD Million)
Table 22 Asia-Pacific: Patient Registry Software Market Size for Health Service Registries, By Country, 2014-2021 (USD Million)
Table 23 Global Patient Registry Software Market Size for Disease Registries, By Type, 2014-2021 (USD Million)
Table 24 Global Patient Registry Software Market Size for Disease Registries, By Region, 2014-2021 (USD Million)
Table 25 North America: Patient Registry Software Market Size for Disease Registries, By Country, 2014-2021 (USD Million)
Table 26 Europe: Patient Registry Software Market Size for Disease Registries, By Country, 2014-2021 (USD Million)
Table 27 Asia-Pacific: Patient Registry Software Market Size for Disease Registries, By Country, 2014-2021 (USD Million)
Table 28 Global Diabetes Registries Market Size, By Region, 2014-2021 (USD Million)
Table 29 North America: Diabetes Registries Market Size, By Country, 2014-2021 (USD Million)
Table 30 Europe: Diabetes Registries Market Size, By Country, 2014-2021 (USD Million)
Table 31 Asia-Pacific: Diabetes Registries Market Size, By Country, 2014-2021 (USD Million)
Table 32 Global Cardiovascular Registries Market Size, By Region, 2014-2021 (USD Million)
Table 33 North America: Cardiovascular Registries Market Size, By Country, 2014-2021 (USD Million)
Table 34 Europe: Cardiovascular Registries Market Size, By Country, 2014-2021 (USD Million)
Table 35 Asia-Pacific: Cardiovascular Registries Market Size, By Country, 2014-2021 (USD Million)
Table 36 Global Cancer Registries Market Size, By Region, 2014-2021 (USD Million)
Table 37 North America: Cancer Registries Market Size, By Country, 2014-2021 (USD Million)
Table 38 Europe: Cancer Registries Market Size, By Country, 2014-2021 (USD Million)
Table 39 Asia-Pacific: Cancer Registries Market Size, By Country, 2014-2021 (USD Million)
Table 40 Global Rare Disease Registries Market Size, By Region, 2014-2021 (USD Million)
Table 41 North America: Rare Disease Registries Market Size, By Country, 2014-2021 (USD Million)
Table 42 Europe: Rare Disease Registries Market Size, By Country, 2014-2021 (USD Million)
Table 43 Asia-Pacific: Rare Disease Registries Market Size, By Country, 2014-2021 (USD Million)
Table 44 Global Asthma Registries Market Size, By Region, 2014-2021 (USD Million)
Table 45 North America: Asthma Registries Market Size, By Country, 2014-2021 (USD Million)
Table 46 Europe: Asthma Registries Market Size, By Country, 2014-2021 (USD Million)
Table 47 Asia-Pacific: Asthma Registries Market Size, By Country, 2014-2021 (USD Million)
Table 48 Global Coronary Disease Registries Market Size, By Region, 2014-2021 (USD Million)
Table 49 North America: Coronary Disease Registries Market Size, By Country, 2014-2021 (USD Million)
Table 50 Europe: Coronary Disease Registries Market Size, By Country, 2014-2021 (USD Million)
Table 51 Asia-Pacific: Coronary Disease Registries Market Size, By Country, 2014-2021 (USD Million)
Table 52 Global Other Disease Registries Market Size, By Region, 2014-2021 (USD Million)
Table 53 North America: Other Disease Registries Market Size, By Country, 2014-2021 (USD Million)
Table 54 Europe: Other Disease Registries Market Size, By Country, 2014-2021 (USD Million)
Table 55 Asia-Pacific: Other Disease Registries Market Size, By Country, 2014-2021 (USD Million)
Table 56 Global Patient Registry Software Market Size, By Product Type, 2014-2021 (USD Million)
Table 57 Global Standalone Patient Registry Software Market Size, By Region, 2014-2021 (USD Million)
Table 58 North America: Standalone Patient Registry Software Market Size, By Country, 2014-2021 (USD Million)
Table 59 Europe: Standalone Patient Registry Software Market Size, By Country, 2014-2021 (USD Million)
Table 60 Asia-Pacific: Standalone Patient Registry Software Market Size, By Country, 2014-2021 (USD Million)
Table 61 Global Integrated Patient Registry Software Market Size, By Region, 2014-2021 (USD Million)
Table 62 North America: Integrated Patient Registry Software Market Size, By Country, 2014-2021 (USD Million)
Table 63 Europe: Integrated Patient Registry Software Market Size, By Country, 2014-2021 (USD Million)
Table 64 Asia-Pacific: Integrated Patient Registry Software Market Size, By Country, 2014-2021 (USD Million)
Table 65 Global Patient Registry Software Market Size, By Pricing Model, 2014–2021 (USD Million)
Table 66 Global Patient Registry Software Market Size for Subscription Models, By Region, 2014–2021 (USD Million)
Table 67 North America: Patient Registry Software Market Size for Subscription Models, By Country, 2014–2021 (USD Million)
Table 68 Europe: Patient Registry Software Market Size for Subscription Models, By Country, 2014–2021 (USD Million)
Table 69 Asia-Pacific: Patient Registry Software Market Size for Subscription Models, By Country, 2014–2021 (USD Million)
Table 70 Global Patient Registry Software Market Size for Ownership Models, By Region, 2014–2021 (USD Million)
Table 71 North America: Patient Registry Software Market Size for Ownership Models, By Country, 2014–2021 (USD Million)
Table 72 Europe: Patient Registry Software Market Size for Ownership Models, By Country, 2014–2021 (USD Million)
Table 73 Asia-Pacific: Patient Registry Software Market Size for Ownership Models, By Country, 2014–2021 (USD Million)
Table 74 Global Patient Registry Software Market Size, By Deployment Model, 2014–2021 (USD Million)
Table 75 Global Patient Registry Software Market Size for On-Premise Models, By Region, 2014–2021 (USD Million)
Table 76 North America: Patient Registry Software Market Size for On-Premise Models, By Country, 2014–2021 (USD Million)
Table 77 Europe: Patient Registry Software Market Size for On-Premise Models, By Country, 2014–2021 (USD Million)
Table 78 Asia-Pacific: Patient Registry Software Market Size for On-Premise Models, By Country, 2014–2021 (USD Million)
Table 79 Global Patient Registry Software Market Size for Cloud-Based Models, By Region, 2014–2021 (USD Million)
Table 80 North America: Patient Registry Software Market Size for Cloud-Based Models, By Country, 2014–2021 (USD Million)
Table 81 Europe: Patient Registry Software Market Size for Cloud-Based Models, By Country, 2014–2021 (USD Million)
Table 82 Asia-Pacific: Patient Registry Software Market Size for Cloud-Based Models, By Country, 2014–2021 (USD Million)
Table 83 Global Patient Registry Software Market Size, By Functionality, 2014-2021 (USD Million)
Table 84 Global Patient Registry Software Market Size for Population Health Management, By Region, 2014-2021 (USD Million)
Table 85 North America: Patient Registry Software Market Size for Population Health Management, By Country, 2014-2021 (USD Million)
Table 86 Europe: Patient Registry Software Market Size for Population Health Management, By Country, 2014-2021 (USD Million)
Table 87 Asia-Pacific: Patient Registry Software Market Size for Population Health Management, By Country, 2014-2021 (USD Million)
Table 88 Global Patient Registry Software Market Size for Patient Care Management, By Region, 2014-2021 (USD Million)
Table 89 North America: Patient Registry Software Market Size for Patient Care Management, By Country, 2014-2021 (USD Million)
Table 90 Europe: Patient Registry Software Market Size for Patient Care Management, By Country, 2014-2021 (USD Million)
Table 91 Asia-Pacific: Patient Registry Software Market Size for Patient Care Management, By Country, 2014-2021 (USD Million)
Table 92 Global Patient Registry Software Market Size for Health Information Exchange, By Region, 2014-2021 (USD Million)
Table 93 North America: Patient Registry Software Market Size for Health Information Exchange, By Country, 2014-2021 (USD Million)
Table 94 Europe: Patient Registry Software Market Size for Health Information Exchange, By Country, 2014-2021 (USD Million)
Table 95 Asia-Pacific: Patient Registry Software Market Size for Health Information Exchange, By Country, 2014-2021 (USD Million)
Table 96 Global Patient Registry Software Market Size for Point-Of-Care Functionality, By Region, 2014-2021 (USD Million)
Table 97 North America: Patient Registry Software Market Size for Point-Of-Care Functionality, By Country, 2014-2021 (USD Million)
Table 98 Europe: Patient Registry Software Market Size for Point-Of-Care Functionality, By Country, 2014-2021 (USD Million)
Table 99 Asia-Pacific: Patient Registry Software Market Size for Point-Of-Care Functionality, By Country, 2014-2021 (USD Million)
Table 100 Global Patient Registry Software Market Size for Product Outcome Evaluation, By Region, 2014-2021 (USD Million)
Table 101 North America: Patient Registry Software Market Size for Product Outcome Evaluation, By Country, 2014-2021 (USD Million)
Table 102 Europe: Patient Registry Software Market Size for Product Outcome Evaluation, By Country, 2014-2021 (USD Million)
Table 103 Asia-Pacific: Patient Registry Software Market Size for Product Outcome Evaluation, By Country, 2014-2021 (USD Million)
Table 104 Global Patient Registry Software Market Size for Medical Research & Clinical Studies, By Region, 2014-2021 (USD Million)
Table 105 North America: Patient Registry Software Market Size for Medical Research & Clinical Studies, By Country, 2014-2021 (USD Million)
Table 106 Europe: Patient Registry Software Market Size for Medical Research & Clinical Studies, By Country, 2014-2021 (USD Million)
Table 107 Asia-Pacific: Patient Registry Software Market Size for Medical Research & Clinical Studies, By Country, 2014-2021 (USD Million)
Table 108 Global Patient Registry Software Market Size, By End User, 2014-2021 (USD Million)
Table 109 Global Patient Registry Software Market Size for Government Organizations & Third-Party Administrators, By Region, 2014-2021 (USD Million)
Table 110 North America: Patient Registry Software Market Size for Government Organizations & Third-Party Administrators, By Country, 2014-2021 (USD Million)
Table 111 Europe: Patient Registry Software Market Size for Government Organizations & Third-Party Administrators, By Country, 2014-2021 (USD Million)
Table 112 Asia-Pacific: Patient Registry Software Market Size for Government Organizations & Third-Party Administrators, By Country, 2014-2021 (USD Million)
Table 113 Global Patient Registry Software Market Size for Hospitals and Medical Practices, By Region, 2014-2021 (USD Million)
Table 114 North America: Patient Registry Software Market Size for Hospitals and Medical Practices, By Country, 2014-2021 (USD Million)
Table 115 Europe: Patient Registry Software Market Size for Hospitals and Medical Practices, By Country, 2014-2021 (USD Million)
Table 116 Asia-Pacific: Patient Registry Software Market Size for Hospitals and Medical Practices, By Country, 2014-2021 (USD Million)
Table 117 Global Patient Registry Software Market Size for Private Payers, By Region, 2014-2021 (USD Million)
Table 118 North America: Patient Registry Software Market Size for Private Payers, By Country, 2014-2021 (USD Million)
Table 119 Europe: Patient Registry Software Market Size for Private Payers, By Country, 2014-2021 (USD Million)
Table 120 Asia-Pacific: Patient Registry Software Market Size for Private Payers, By Country, 2014-2021 (USD Million)
Table 121 Global Patient Registry Software Market Size for Pharmaceutical and Medical Device Companies, By Region, 2014-2021 (USD Million)
Table 122 North America: Patient Registry Software Market Size for Pharmaceutical and Medical Device Companies, By Country, 2014-2021 (USD Million)
Table 123 Europe: Patient Registry Software Market Size for Pharmaceutical and Medical Device Companies, By Country, 2014-2021 (USD Million)
Table 124 Asia-Pacific: Patient Registry Software Market Size for Pharmaceutical and Medical Device Companies, By Country, 2014-2021 (USD Million)
Table 125 Global Patient Registry Software Market Size for Research Centers, By Region, 2014-2021 (USD Million)
Table 126 North America: Patient Registry Software Market Size for Research Centers, By Country, 2014-2021 (USD Million)
Table 127 Europe: Patient Registry Software Market Size for Research Centers, By Country, 2014-2021 (USD Million)
Table 128 Asia-Pacific: Patient Registry Software Market Size for Research Centers, By Country, 2014-2021 (USD Million)
Table 129 Global Patient Registry Software Market Size, By Region, 2014–2021 (USD Million)
Table 130 North America: Patient Registry Software Market Size, By Country, 2014–2021 (USD Million)
Table 131 North America: Patient Registry Software Market Size, By Product, 2014–2021 (USD Million)
Table 132 North America: Patient Registry Software Market Size, By Pricing Model, 2014–2021 (USD Million)
Table 133 North America: Patient Registry Software Market Size, By Deployment Model, 2014–2021 (USD Million)
Table 134 North America: Patient Registry Software Market Size, By Type of Database, 2014–2021 (USD Million)
Table 135 North America: Product Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 136 North America: Disease Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 137 North America: Patient Registry Software Market Size, By Functionality, 2014–2021 (USD Million)
Table 138 North America: Patient Registry Software Market Size, By End User, 2014–2021 (USD Million)
Table 139 U.S.: Patient Registry Software Market Size, By Product, 2014–2021 (USD Million)
Table 140 U.S.: Patient Registry Software Market Size, By Pricing Model, 2014–2021 (USD Million)
Table 141 U.S.: Patient Registry Software Market Size, By Deployment Model, 2014–2021 (USD Million)
Table 142 U.S.: Patient Registry Software Market Size, By Type of Database, 2014–2021 (USD Million)
Table 143 U.S.: Product Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 144 U.S.: Disease Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 145 U.S.: Patient Registry Software Market Size, By Functionality, 2014–2021 (USD Million)
Table 146 U.S.: Patient Registry Software Market Size, By End User, 2014–2021 (USD Million)
Table 147 Canada: Patient Registry Software Market Size, By Product, 2014–2021 (USD Million)
Table 148 Canada: Patient Registry Software Market Size, By Pricing Model, 2014–2021 (USD Million)
Table 149 Canada: Patient Registry Software Market Size, By Deployment Model, 2014–2021 (USD Million)
Table 150 Canada: Patient Registry Software Market Size, By Type of Database, 2014–2021 (USD Million)
Table 151 Canada: Product Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 152 Canada: Disease Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 153 Canada: Patient Registry Software Market Size, By Functionality, 2014–2021 (USD Million)
Table 154 Canada: Patient Registry Software Market Size, By End User, 2014–2021 (USD Million)
Table 155 Europe: Patient Registry Software Market Size, By Country, 2014–2021 (USD Million)
Table 156 Europe: Patient Registry Software Market Size, By Product, 2014–2021 (USD Million)
Table 157 Europe: Patient Registry Software Market Size, By Pricing Model, 2014–2021 (USD Million)
Table 158 Europe: Patient Registry Software Market Size, By Deployment Model, 2014–2021 (USD Million)
Table 159 Europe: Patient Registry Software Market Size, By Type of Database, 2014–2021 (USD Million)
Table 160 Europe: Product Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 161 Europe: Disease Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 162 Europe: Patient Registry Software Market Size, By Functionality, 2014–2021 (USD Million)
Table 163 Europe: Patient Registry Software Market Size, By End User, 2014–2021 (USD Million)
Table 164 Germany: Patient Registry Software Market Size, By Product, 2014–2021 (USD Million)
Table 165 Germany: Patient Registry Software Market Size, By Pricing Model, 2014–2021 (USD Million)
Table 166 Germany: Patient Registry Software Market Size, By Deployment Model, 2014–2021 (USD Million)
Table 167 Germany: Patient Registry Software Market Size, By Type of Database, 2014–2021 (USD Million)
Table 168 Germany: Product Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 169 Germany: Disease Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 170 Germany: Patient Registry Software Market Size, By Functionality, 2014–2021 (USD Million)
Table 171 Germany: Patient Registry Software Market Size, By End User, 2014–2021 (USD Million)
Table 172 France: Patient Registry Software Market Size, By Product, 2014–2021 (USD Million)
Table 173 France: Patient Registry Software Market Size, By Pricing Model, 2014–2021 (USD Million)
Table 174 France: Patient Registry Software Market Size, By Deployment Model, 2014–2021 (USD Million)
Table 175 France: Patient Registry Software Market Size, By Type of Database, 2014–2021 (USD Million)
Table 176 France: Product Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 177 France: Disease Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 178 France: Patient Registry Software Market Size, By Functionality, 2014–2021 (USD Million)
Table 179 France: Patient Registry Software Market Size, By End User, 2014–2021 (USD Million)
Table 180 U.K.: Patient Registry Software Market Size, By Product, 2014–2021 (USD Million)
Table 181 U.K.: Patient Registry Software Market Size, By Pricing Model, 2014–2021 (USD Million)
Table 182 U.K.: Patient Registry Software Market Size, By Deployment Model, 2014–2021 (USD Million)
Table 183 U.K.: Patient Registry Software Market Size, By Type of Database, 2014–2021 (USD Million)
Table 184 U.K.: Product Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 185 U.K.: Disease Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 186 U.K.: Patient Registry Software Market Size, By Functionality, 2014–2021 (USD Million)
Table 187 U.K.: Patient Registry Software Market Size, By End User, 2014–2021 (USD Million)
Table 188 RoE: Patient Registry Software Market Size, By Product, 2014–2021 (USD Million)
Table 189 RoE: Patient Registry Software Market Size, By Pricing Model, 2014–2021 (USD Million)
Table 190 RoE: Patient Registry Software Market Size, By Deployment Model, 2014–2021 (USD Million)
Table 191 RoE: Patient Registry Software Market Size, By Type of Database, 2014–2021 (USD Million)
Table 192 RoE: Product Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 193 RoE: Disease Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 194 RoE: Patient Registry Software Market Size, By Functionality, 2014–2021 (USD Million)
Table 195 RoE: Patient Registry Software Market Size, By End User, 2014–2021 (USD Million)
Table 196 Asia-Pacific: Patient Registry Software Market Size, By Country, 2014–2021 (USD Million)
Table 197 Asia-Pacific: Patient Registry Software Market Size, By Product, 2014–2021 (USD Million)
Table 198 Asia-Pacific: Patient Registry Software Market Size, By Pricing Model, 2014–2021 (USD Million)
Table 199 Asia-Pacific: Patient Registry Software Market Size, By Deployment Model, 2014–2021 (USD Million)
Table 200 Asia-Pacific: Patient Registry Software Market Size, By Type of Database, 2014–2021 (USD Million)
Table 201 Asia-Pacific: Product Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 202 Asia-Pacific: Disease Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 203 Asia-Pacific: Patient Registry Software Market Size, By Functionality, 2014–2021 (USD Million)
Table 204 Asia-Pacific: Patient Registry Software Market Size, By End User, 2014–2021 (USD Million)
Table 205 Japan: Patient Registry Software Market Size, By Product, 2014–2021 (USD Million)
Table 206 Japan: Patient Registry Software Market Size, By Pricing Model, 2014–2021 (USD Million)
Table 207 Japan: Patient Registry Software Market Size, By Deployment Model, 2014–2021 (USD Million)
Table 208 Japan: Patient Registry Software Market Size, By Type of Database, 2014–2021 (USD Million)
Table 209 Japan: Product Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 210 Japan: Disease Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 211 Japan: Patient Registry Software Market Size, By Functionality, 2014–2021 (USD Million)
Table 212 Japan: Patient Registry Software Market Size, By End User, 2014–2021 (USD Million)
Table 213 China: Patient Registry Software Market Size, By Product, 2014–2021 (USD Million)
Table 214 China: Patient Registry Software Market Size, By Pricing Model, 2014–2021 (USD Million)
Table 215 China: Patient Registry Software Market Size, By Deployment Model, 2014–2021 (USD Million)
Table 216 China: Patient Registry Software Market Size, By Type of Database, 2014–2021 (USD Million)
Table 217 China: Product Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 218 China: Disease Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 219 China: Patient Registry Software Market Size, By Functionality, 2014–2021 (USD Million)
Table 220 China: Patient Registry Software Market Size, By End User, 2014–2021 (USD Million)
Table 221 India: Patient Registry Software Market Size, By Product, 2014–2021 (USD Million)
Table 222 India: Patient Registry Software Market Size, By Pricing Model, 2014–2021 (USD Million)
Table 223 India: Patient Registry Software Market Size, By Deployment Model, 2014–2021 (USD Million)
Table 224 India: Patient Registry Software Market Size, By Type of Database, 2014–2021 (USD Million)
Table 225 India: Product Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 226 India: Disease Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 227 India: Patient Registry Software Market Size, By Functionality, 2014–2021 (USD Million)
Table 228 India: Patient Registry Software Market Size, By End User, 2014–2021 (USD Million)
Table 229 RoAPAC: Patient Registry Software Market Size, By Product, 2014–2021 (USD Million)
Table 230 RoAPAC: Patient Registry Software Market Size, By Pricing Model, 2014–2021 (USD Million)
Table 231 RoAPAC: Patient Registry Software Market Size, By Deployment Model, 2014–2021 (USD Million)
Table 232 RoAPAC: Patient Registry Software Market Size, By Type of Database, 2014–2021 (USD Million)
Table 233 RoAPAC: Product Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 234 RoAPAC: Disease Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 235 RoAPAC: Patient Registry Software Market Size, By Functionality, 2014–2021 (USD Million)
Table 236 RoAPAC: Patient Registry Software Market Size, By End User, 2014–2021 (USD Million)
Table 237 RoW: Patient Registry Software Market Size, By Product, 2014–2021 (USD Million)
Table 238 RoW: Patient Registry Software Market Size, By Pricing Model, 2014–2021 (USD Million)
Table 239 RoW: Patient Registry Software Market Size, By Deployment Model, 2014–2021 (USD Million)
Table 240 RoW: Patient Registry Software Market Size, By Type of Database, 2014–2021 (USD Million)
Table 241 RoW: Product Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 242 RoW: Disease Registry Software Market Size, By Type, 2014–2021 (USD Million)
Table 243 RoW: Patient Registry Software Market Size, By Functionality, 2014–2021 (USD Million)
Table 244 RoW: Patient Registry Software Market Size, By End User, 2014–2021 (USD Million)
Table 245 Partnerships, Agreements, Collaborations, and Contracts (2013-2016)
Table 246 New Product Launches & Product Upgrades (2013-2016)
Table 247 Acquisitions (2013-2016)
Table 248 Expansions (2013-2016)
Table 249 Others (2013-2016)
Table 250 Exchange Rate (Utilized for the Conversion of Eur to USD)


List of Figures (54 Figures)

Figure 1 Research Design
Figure 2 Market Size Estimation: Bottom-Up Approach
Figure 3 Market Size Estimation: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Key Data From Secondary Sources
Figure 7 Key Data From Primary Sources
Figure 8 Key Insights From Industry Experts
Figure 9 Disease Registries Segment to Register High Growth During the Forecast Period
Figure 10 Standalone Software Segment to Dominate the Patient Registry Software Market, By Product Type (2016-2021)
Figure 11 Subscription Models Segment to Register Significant Growth During the Forecast Period
Figure 12 Cloud-Based Models to Grow at the Highest CAGR During the Forecast Period
Figure 13 Patient Care Management Segment to Grow at the Highest CAGR During the Forecast Period
Figure 14 Government Organizations & TPAS Segment to Dominate the Market (2016-2021)
Figure 15 North America Expected to Hold the Largest Share in 2016
Figure 16 Disease Registries to Offer High Growth Opportunities During the Forecast Period
Figure 17 Integrated Software Segment to Grow at the Highest CAGR During the Forecast Period
Figure 18 Cloud-Based Models to Grow at the Highest CAGR During the Forecast Period
Figure 19 Subscription Models to Witness the Highest Growth Rate Between 2016 and 2021
Figure 20 Patient Care Management Segment to Dominate the Market By 2021
Figure 21 Hospitals and Medical Practices to Grow at the Highest CAGR During the Forecast Period
Figure 22 Asia-Pacific to Witness the Highest Growth During the Forecast Period
Figure 23 Global Patient Registry Software Market Segmentation
Figure 24 Patient Registry Software Market: Drivers, Restraints, Opportunities, and Challenges
Figure 25 Disease Registries Segment to Witness Highest Growth During the Forecast Period
Figure 26 Medical Device Registries to Dominate the Market During the Forecast Period
Figure 27 North America to Dominate the Health Service Registries Market During the Forecast Period
Figure 28 Cancer Registries to Grow at the Highest CAGR During the Forecast Period
Figure 29 Integrated Software Segment to Witness Highest Growth During the Forecast Period
Figure 30 North America to Dominate the Integrated Software Market in 2016
Figure 31 Subscription Model to Witness Highest Growth During the Forecast Period
Figure 32 North America to Dominate the Ownership Models Segment in 2016
Figure 33 Cloud-Based Models to Witness Highest Growth During the Forecast Period
Figure 34 North America to Dominate the Cloud-Based Software Market in 2016
Figure 35 Patient Care Management Segment to Witness Highest Growth During the Forecast Period
Figure 36 North America to Dominate the Patient Care Management Market During the Forecast Period
Figure 37 Hospitals and Medical Practices Segment to Witness Highest Growth During the Forecast Period
Figure 38 Asia-Pacific Patient Registry Software Market for Hospitals and Medical Practices to Grow at the Highest CAGR During the Forecast Period
Figure 39 Asia-Pacific to Witness the Highest Growth During the Forecast Period
Figure 40 North America: Patient Registry Software Market Snapshot (2016)
Figure 41 Europe: Patient Registry Software Market Snapshot (2016)
Figure 42 Asia-Pacific: Patient Registry Software Market Snapshot (2016)
Figure 43 RoW: Patient Registry Software Market Snapshot (2016)
Figure 44 Key Players Adopted Organic as Well as Inorganic Growth Strategies Between 2013 and 2016
Figure 45 Market Evolution Framework—Partnerships, Agreements, Contracts, and Collaborations are Fueling Market Growth
Figure 46 Battle for Market Share: Partnerships, Collaborations, Agreements, and Contracts Was the Key Strategy Adopted By Market Players
Figure 47 Geographic Revenue Mix of Top Market Players
Figure 48 IBM Corporation: Company Snapshot
Figure 49 Quintiles Transnational Holdings, Inc.: Company Snapshot
Figure 50 Premier, Inc.: Company Snapshot
Figure 51 IFA Systems AG: Company Snapshot
Figure 52 Inc Research Holdings, Inc.: Company Snapshot
Figure 53 Mckesson Corporation: Company Snapshot
Figure 54 Unitedhealth Group: Company Snapshot

The patient registry software market is segmented on the basis of product type, pricing model, deployment model, type of database, functionality, end user, and region. Based on product type, the patient registry software market is segmented into integrated and standalone software. The standalone software segment is expected to account for the largest market share in 2016.  This can be attributed to the significant usage of standalone software by government organizations and TPAs for population health management. On the basis of deployment model, the patient registry software market is further divided into on-premise and cloud-based models. The cloud-based models segment is expected to grow at the highest CAGR during the forecast period. The main factors aiding its growth are cost-effectiveness, large storage capacity, easy accessibility, flexibility, and regular automatic upgradation. Based on pricing model, the patient registry software market is segmented into subscription and ownership models. The subscription models segment is expected to grow at the highest CAGR during the forecast period due to its advantages such as cost-effectiveness, flexibility, and ease of use.

The global patient registry software market is expected to reach USD 1,314.3 Million by 2021 from USD 734.7 Million in 2016, at a CAGR of 12.3% during the forecast period.

Based on type of databases, the market is segmented into product registries (medical device and drug registries), health service registries, and disease registries (diabetes registries, cardiovascular registries, cancer registries, rare disease registries, asthma registries, chronic kidney disease registries, and other disease registries). The disease registries segment is expected to dominate the market in 2016 as there are large numbers of disease registries across the globe.

Based on functionality, the patient registry software market is segmented into population health management (PHM), patient care management, health information exchange (HIE), point of care, product outcome evaluation, and medical research and clinical studies. The population health management segment is estimated to dominate the market in 2016. This can primarily be attributed to increasing government initiatives for encouraging PHM.

Based on end user, the market is segmented into government organizations & TPAs (third-party administrators), hospitals and medical practices, private payers, pharmaceutical, biotechnology and medical device companies, and research centers. The hospitals and medical practices segment is expected to grow at the highest CAGR due to increasing focus on improving the quality of patient care, growing adoption of EHRs, and for fulfilling pay-for-performance initiatives.

Patient Registry Software Market

The market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World. While North America is expected to dominate the market in 2016, Asia-Pacific is expected to grow at the highest CAGR during the forecast period. Large population base, rising prevalence of chronic diseases, improvement of healthcare systems, and increasing government initiatives for the modernization of healthcare infrastructure will drive the growth of the patient registry software market in Asia-Pacific.

Key players in the patient registry software market include Global Vision Technologies, Inc. (U.S.), Dacima Software, Inc. (Canada), FIGmd, Inc. (U.S.), CECity.com, Inc. (U.S.), Liaison Technologies, Inc. (U.S.), Advertek Incorporated (U.S.), ImageTrend, Inc. (U.S.), Phytel, Inc. (U.S.), Velos, Inc. (U.S.), INC Research Holdings, Inc. (U.S.), Quintiles Transnational Holdings Inc. (U.S.), IFA Systems AG (Germany), McKesson Corporation (U.S.), Optum, Inc. (U.S.), M2S, Inc. (U.S.), and Telligen, Inc. (U.S.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Healthcare IT Markets on KnowledgeStore
Request Demo